CathWorks

cath.works

CathWorks is a medical technology company dedicated to transforming cardiovascular disease diagnosis and treatment through its innovative FFRangio System. This system leverages artificial intelligence and advanced computational science to derive physiologic information from standard angiograms, enabling interventional cardiologists to make more informed treatment decisions. With regulatory approvals in the US, EU, and Japan, CathWorks is positioned to disrupt traditional methods of assessing coronary artery disease, offering a more efficient and accurate alternative to invasive procedures. The company has gained traction through strategic partnerships, including one with Medtronic, and is actively involved in clinical studies to validate its technology's effectiveness.